KLEANTHIS G XANTHOPOULOS
CIK 1283304 · President and CEO · last filed 2021-06-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
5
Total Filings
57
Lifetime Open-Market Net
-$8.32M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Zosano Pharma Corp (ZSAN) Delisted | Director | 23,596 | $0.56 | $13.2K | $21.0K | 9 | 2021-06-14 |
| SEELOS THERAPEUTICS, INC. (APRI) Delisted | Director | 112,075 | — | — | -$123.2K | 19 | 2018-01-08 |
| Regulus Therapeutics Inc. (RGLS) Delisted | President and CEO | 83,921 | $8.16 | $684.8K | -$8.23M | 19 | 2015-04-21 |
| ANADYS PHARMACEUTICALS INC (ANDS) Delisted | Director | 184,543 | — | — | $14.0K | 9 | 2011-05-27 |
| IONIS PHARMACEUTICALS INC (ISIS) Delisted | President of Regulus | — | — | — | $0 | 1 | 2007-12-05 |
Recent Filings · Page 5 of 6
57 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-03-21 | SEELOS THERAPEUTICS, INC. (APRI) Delisted | Sell (S) | −2,864 | -$7.2K | EDGAR |
| 2013-01-08 | SEELOS THERAPEUTICS, INC. (APRI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-12-13 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-10-01 | SEELOS THERAPEUTICS, INC. (APRI) Delisted | Sell (S) | −3,125 | -$10.2K | EDGAR |
| 2012-08-17 | SEELOS THERAPEUTICS, INC. (APRI) Delisted | Sell (S) | −12,500 | -$37.7K | EDGAR |
| 2012-01-04 | SEELOS THERAPEUTICS, INC. (APRI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-11-21 | SEELOS THERAPEUTICS, INC. (APRI) Delisted | Grant (A) | +100,000 | $0 | EDGAR |
| 2011-05-27 | ANADYS PHARMACEUTICALS INC (ANDS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-05-28 | ANADYS PHARMACEUTICALS INC (ANDS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-05-29 | ANADYS PHARMACEUTICALS INC (ANDS) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.